
Aveanna Healthcare Holdings, Inc. Experiences Revision in Stock Evaluation Amid Mixed Financial Metrics
2025-11-10 16:27:39Aveanna Healthcare Holdings, Inc. has recently adjusted its valuation, with a P/E ratio of 25 and low PEG ratio of 0.01. The company shows a ROCE of 13.80%, but has a negative ROE. Its valuation metrics present a mixed comparison with industry peers, indicating an evolving market position.
Read More
Aveanna Healthcare Hits Day Low of $7.81 Amid Price Pressure
2025-11-07 16:43:32Aveanna Healthcare Holdings, Inc. faced a significant stock decline today, reaching an intraday low amid a challenging trading session. Despite recent setbacks, the company has shown strong annual performance compared to broader market indices. However, concerns about its financial health persist, particularly regarding profitability and debt levels.
Read More
Aveanna Healthcare Faces Weak Start with Significant Gap Down Amid Market Concerns
2025-11-07 16:27:43Aveanna Healthcare Holdings, Inc. experienced a notable decline in stock performance, opening with a significant loss. The company's market capitalization is around USD 1,725 million, with concerning financial metrics, including a negative return on equity and a complex debt-to-equity structure. Technical indicators show mixed signals regarding future performance.
Read More
Aveanna Healthcare Hits Day Low of $8.73 Amid Price Pressure
2025-10-23 17:40:38Aveanna Healthcare Holdings, Inc. faced a notable decline in stock value on October 22, 2025, reaching an intraday low. Despite recent gains, the company grapples with financial challenges, including a negative book value and a high debt-to-equity ratio, complicating its market position in the Pharmaceuticals & Biotechnology sector.
Read More
Aveanna Healthcare Faces Weak Start with 9.87% Gap Down Amid Market Concerns
2025-10-23 17:26:43Aveanna Healthcare Holdings, Inc. experienced a notable decline in its stock price today, contrasting with its recent monthly performance, which showed a significant gain. The company's technical indicators present a mixed outlook, while its financial metrics reveal a substantial market capitalization and a negative return on equity.
Read More
Aveanna Healthcare Reaches New 52-Week High of $9.82
2025-10-16 18:30:46Aveanna Healthcare Holdings, Inc. achieved a new 52-week high of USD 9.82 on October 15, 2025, reflecting a substantial increase over the past year. With a market capitalization of USD 1,725 million, the company operates in the Pharmaceuticals & Biotechnology sector, despite facing challenges such as negative return on equity.
Read More
Aveanna Healthcare Holdings Hits New 52-Week High of $9.36
2025-10-15 17:14:32Aveanna Healthcare Holdings, Inc. achieved a new 52-week high of USD 9.36 on October 14, 2025, reflecting a substantial increase of 272.8% over the past year. The company, with a market capitalization of USD 1,725 million, operates in the Pharmaceuticals & Biotechnology sector and has a negative debt-to-equity ratio.
Read More
Aveanna Healthcare Holdings Hits New 52-Week High at $9.03
2025-10-02 22:43:06Aveanna Healthcare Holdings, Inc. has achieved a new 52-week high of USD 9.03, reflecting a substantial increase in stock performance over the past year. With a market capitalization of USD 1,725 million, the company operates in the Pharmaceuticals & Biotechnology sector, facing unique financial challenges.
Read More
Aveanna Healthcare Hits New 52-Week High of $8.79, Up 250%
2025-09-29 14:35:00Aveanna Healthcare Holdings, Inc. achieved a new 52-week high of USD 8.79 on September 26, 2025, reflecting a substantial increase in stock performance over the past year. The company, with a market cap of USD 1,725 million, faces challenges in its financial metrics while navigating the pharmaceuticals and biotechnology sector.
Read More





